Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model.

Gynecologic Oncology
Enes TaylanSandra Orsulic

Abstract

To investigate the anti-tumor effect of a newly-developed dual inhibitor (APCS-540) of glycogen synthase kinase 3 beta (GSK3B) and histone deacetylases (HDACs) in ovarian cancer cells. The effects of APCS-540 on cancer cell proliferation, migration, invasion and cancer stemness were investigated in vitro in human (KURAMOCHI, OVCA420, OVSAHO) and mouse (BR-Luc, ID8, MOSE-HRas-Myc) ovarian cancer cells. Cisplatin-sensitive (A2780) and cisplatin-resistant (A2780cis) cell lines were used to evaluate APCS-540's effect on chemoresistance. The immunocompetent syngeneic mouse model BR-Luc was used to test the effect of APCS-540 on ovarian cancer progression and survival. APCS-540 showed significant anti-tumor effects in vitro in both human and mouse ovarian cancer cells. Importantly, APCS-540 demonstrated marked cytotoxicity against cisplatin-resistant cancer cells and reversed cisplatin-resistance when used in combination with platinum. APCS-540 significantly decreased cancer cell invasion. A significant 66% increase in survival was observed in mice treated with APCS-540 compared to control mice. Dual inhibition of GSK3B and HDACs via APCS-540 showed potent anti-tumor activity in vitro and in vivo, suggesting that APCS-540 may provide...Continue Reading

References

Jun 3, 2004·Nature Reviews. Drug Discovery·Philip Cohen, Michel Goedert
Feb 6, 2010·Journal of Hematology & Oncology·Jiahuai TanDelong Liu
Jul 10, 2012·Cell·Mark A Dawson, Tony Kouzarides
Jul 31, 2013·Current Pharmaceutical Design·Juan RenJinping Li
Sep 26, 2013·Nature Reviews. Cancer·Caitriona HolohanPatrick G Johnston
Sep 10, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Junzo HamanishiIkuo Konishi
Nov 13, 2015·Scientific Reports·Cuiling MaJian Wang
Jan 16, 2016·Cell Metabolism·Natalya N Pavlova, Craig B Thompson
Aug 26, 2016·Nature Reviews. Disease Primers·Ursula A MatulonisBeth Y Karlan
Jan 6, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amy WalzAndrew P Mazar
May 16, 2018·Cancer Cell·David J KonieczkowskiLevi A Garraway
Aug 19, 2018·Scientific Reports·Dongyu JiaSandra Orsulic
Sep 25, 2018·NPJ Precision Oncology·Soochi KimYong Sang Song
Oct 2, 2019·Nature Reviews. Clinical Oncology·Daphné MorelSophie Postel-Vinay

❮ Previous
Next ❯

Citations

May 4, 2021·Biochemical and Biophysical Research Communications·Feikai LinXipeng Wang

❮ Previous
Next ❯

Methods Mentioned

BETA
bioluminescence imaging
Assay
PCR
dissection

Software Mentioned

Living Image
Metavert
GraphPad Prism

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.